menu
    • menu

    Company profile for Exothera

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Exothera is a uniquely positioned viral vector CDMO leveraging standard and innovative bioproduction platforms to deliver affordable cell and gene therapies. Based on our extensive technology knowledge we are able to select adapted technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ExotheraBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    Avenue de Tervueren 270, 1150 Brussels
    Telephone
    Telephone
    +32 (0) 2 319 58 36
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://exothera.world/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NurExone Biologic Expands US Presence With Conference Talk
    NurExone Biologic Expands US Presence With Conference Talk

    14 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/14/3026870/0/en/NurExone-Biologic-Continues-Expansion-of-U-S-Presence-and-Awareness-with-Prestigious-Conference-Presentation.html

    GLOBENEWSWIRE
    14 Feb 2025
    Share Share
    Exothera announced the appointment of Cedric Volanti as CEO.
    Exothera announced the appointment of Cedric Volanti as CEO.

    08 Oct 2024

    // PRESS RELEASE

    https://exothera.world/5907-2/

    PRESS RELEASE
    08 Oct 2024
    Share Share
    Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy
    Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy

    11 Jun 2024

    // PRESS RELEASE

    https://exothera.world/asgard-therapeutics-selects-exothera-to-bring-their-viral-vector-based-immunotherapy-candidate-at-108-to-clinical-trial-stage/

    PRESS RELEASE
    11 Jun 2024
    Share Share
    Exothera Launches Nucleic Acids Service Offering Powered by Ntensify
    Exothera Launches Nucleic Acids Service Offering Powered by Ntensify

    26 Mar 2024

    // PRESS RELEASE

    https://exothera.world/exothera-pledges-to-fast-track-rna-therapies-with-expansion-of-world-first-continuous-rna-manufacturing-solution-into-north-america/

    PRESS RELEASE
    26 Mar 2024
    Share Share
    NIH and Exothera partner to produce GMP intranasal vaccine against SARS-CoV-2
    NIH and Exothera partner to produce GMP intranasal vaccine against SARS-CoV-2

    24 Aug 2023

    // ONCLIVE

    https://www.indianpharmapost.com/news/nih-and-exothera-partner-to-produce-gmp-intranasal-vaccine-against-sars-cov-2-for-clinical-phase-iii-trial-in-africa-and-us-14570

    ONCLIVE
    24 Aug 2023
    Share Share
    Meissa Vaccines Enters into cGMP Manufacturing Agreement for Pediatric RSV Vaccine Candidate for Phase 2 Clinical Trials
    Meissa Vaccines Enters into cGMP Manufacturing Agreement for Pediatric RSV Vaccine Candidate for Phase 2 Clinical Trials

    28 Jun 2023

    // PRESS RELEASE

    https://exothera.world/meissa-vaccines-enters-into-cgmp-manufacturing-agreement-for-pediatric-rsv-vaccine-candidate-for-phase-2-clinical-trials/

    PRESS RELEASE
    28 Jun 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search